Buskwofie A, David-West G, Clare CA (2020) A review of cervical cancer: incidence and disparities. J Natl Med Assoc 112(2):229–232. https://doi.org/10.1016/j.jnma.2020.03.002

Article  PubMed  Google Scholar 

Cao W, Chen HD, Yu YW, Li N, Chen WQ (2021) Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (engl) 134(7):783–791. https://doi.org/10.1097/CM9.0000000000001474

Article  PubMed  Google Scholar 

Ding Y, Yang M, She S, Min H, Xv X, Ran X et al (2015) iTRAQ-based quantitative proteomic analysis of cervical cancer. Int J Oncol 46(4):1748–1758. https://doi.org/10.3892/ijo.2015.2859

Article  CAS  PubMed  Google Scholar 

Garrido-Tapia M, Hernandez CJ, Ascui G, Kramm K, Morales M, Ga Rate V et al (2017) STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells. Immunobiology 222(11):1043–1051. https://doi.org/10.1016/j.imbio.2017.05.009

Article  CAS  PubMed  Google Scholar 

Gutierrez-Hoya A, Soto-Cruz I (2020) Role of the JAK/STAT pathway in cervical cancer: its relationship with HPV E6/E7 oncoproteins. Cells. https://doi.org/10.3390/cells9102297

Article  PubMed  PubMed Central  Google Scholar 

Howarth M, Williams A, Tolstrup AB, Elliott T (2004) Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci USA 101(32):11737–11742. https://doi.org/10.1073/pnas.0306294101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang H, Weng H, Chen J (2020) m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell 37(3):270–288. https://doi.org/10.1016/j.ccell.2020.02.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Deng Y, Boakye D, Tin MS, Lok V, Zhang L et al (2022) Global distribution, risk factors, and recent trends for cervical cancer: a worldwide country-level analysis. Gynecol Oncol 164(1):85–92. https://doi.org/10.1016/j.ygyno.2021.11.005

Article  PubMed  Google Scholar 

Hulpke S, Tampe R (2013) The MHC I loading complex: a multitasking machinery in adaptive immunity. Trends Biochem Sci 38(8):412–420. https://doi.org/10.1016/j.tibs.2013.06.003

Article  CAS  PubMed  Google Scholar 

Jiang Q, Pan HY, Ye DX, Zhang P, Zhong LP, Zhang ZY (2010) Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome. Tumour Biol 31(5):451–459. https://doi.org/10.1007/s13277-010-0054-4

Article  CAS  PubMed  Google Scholar 

Jin Z, Han Y, Zhang J, Liu Z, Li R, Liu Z (2024) Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells. J Gene Med 26(1):e3657. https://doi.org/10.1002/jgm.3657

Article  CAS  PubMed  Google Scholar 

Koel M, Vosa U, Joeloo M, Lall K, Gualdo NP, Laivuori H et al (2023) GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer. Hum Mol Genet 32(12):2103–2116. https://doi.org/10.1093/hmg/ddad043

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Du M, Xu K, Ben S, Zhu T, Guo M et al (2023) Genetic modulation of BET1L confers colorectal cancer susceptibility by reducing miRNA binding and m6A modification. Cancer Res 83(13):2142–2154. https://doi.org/10.1158/0008-5472.CAN-22-0065

Article  CAS  PubMed  Google Scholar 

Lin H, Zhang R, Wu W, Lei L (2020a) Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma. Cancer Genet 245:27–34. https://doi.org/10.1016/j.cancergen.2020.04.076

Article  CAS  PubMed  Google Scholar 

Lin W, Xu H, Yuan Q, Zhang S (2020b) Integrative genomic analysis predicts regulatory role of N (6)-methyladenosine-associated SNPs for adiposity. Front Cell Dev Biol 8:551. https://doi.org/10.3389/fcell.2020.00551

Article  PubMed  PubMed Central  Google Scholar 

Popalis ML, Ramirez SI, Leach KM, Granzow ME, Stoltzfus KC, Moss JL (2022) Improving cervical cancer screening rates: a scoping review of resources and interventions. Cancer Causes Control 33(11):1325–1333. https://doi.org/10.1007/s10552-022-01618-2

Article  PubMed  PubMed Central  Google Scholar 

Ramachandran D, Wang Y, Schurmann P, Hulse F, Mao Q, Jentschke M et al (2021) Association of genomic variants at PAX8 and PBX2 with cervical cancer risk. Int J Cancer. https://doi.org/10.1002/ijc.33614

Article  PubMed  Google Scholar 

Ramachandran D, Dennis J, Fachal L, Schurmann P, Bousset K, Hulse F et al (2022) Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer. Hum Mol Genet 31(15):2483–2497. https://doi.org/10.1093/hmg/ddac031

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shao J, Lou X, Wang J, Zhang J, Chen C, Hua D et al (2013) Targeted re-sequencing identified rs3106189 at the 5’ UTR of TAPBP and rs1052918 at the 3’ UTR of TCF3 to be associated with the overall survival of colorectal cancer patients. PLoS ONE 8(8):e70307. https://doi.org/10.1371/journal.pone.0070307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K et al (2013) Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS ONE 8(7):e67849. https://doi.org/10.1371/journal.pone.0067849

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan R, Liu J, Wang J, Zhang W, He M, Zhang Y (2023) Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway. Sci Rep 13(1):5363. https://doi.org/10.1038/s41598-023-32607-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tye H, Kennedy CL, Najdovska M, McLeod L, McCormack W, Hughes N et al (2012) STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 22(4):466–478. https://doi.org/10.1016/j.ccr.2012.08.010

Article  CAS  PubMed  Google Scholar 

Wang N, He X, Zhou R, Jia G, Qiao Q (2018) STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway. Onco Targ Ther 11:3475–3484. https://doi.org/10.2147/OTT.S158764

Article  Google Scholar 

Wang S, Zhu H, Ding B, Feng X, Zhao W, Cui M et al (2019) Genetic variants in microRNAs are associated with cervical cancer risk. Mutagenesis 34(2):127–133. https://doi.org/10.1093/mutage/gez005

Article  CAS  PubMed  Google Scholar 

Wu M, Chen G, Liao X, Xiao L, Zheng J (2022) YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1. Drug Dev Res 83(5):1190–1200. https://doi.org/10.1002/ddr.21942

Article  CAS  PubMed  Google Scholar 

Wu L, Yan J, Bai Y, Chen F, Zou X, Xu J et al (2023) An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell Res 33(8):585–603. https://doi.org/10.1038/s41422-023-00831-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia C, Basu P, Kramer BS, Li H, Qu C, Yu XQ et al (2023) Cancer screening in China: a steep road from evidence to implementation. Lancet Public Health 8(12):e996–e1005. https://doi.org/10.1016/S2468-2667(23)00186-X

Article  PubMed  PubMed Central